R J Fass, R L Perkins, S Saslaw. Show Affiliations »
Abstract
Entities: Chemical Species
Mesh: See more » AdolescentAdultAgedBronchitis/drug therapyCephalosporins/adverse effectsCephalosporins/bloodCephalosporins/pharmacologyCephalosporins/therapeutic useCephalothin/therapeutic useDrug Resistance, Microbial/drug effectsHumansKanamycin/therapeutic useMaleMicrobial Sensitivity TestsMiddle AgedPharyngitis/drug therapyPneumococcal Infections/drug therapyPneumonia/drug therapyPneumonia, Staphylococcal/drug therapyProstatitis/drug therapySepsis/drug therapyStaphylococcal Infections/drug therapyStreptococcal Infections/drug therapyUrinary Tract Infections/drug therapy
Substances: See more » CephalosporinsKanamycinCephalothin
Year: 1970 PMID: 5466475
Source DB: PubMed Journal: Am J Med Sci ISSN: 0002-9629 Impact factor: 2.378